These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 4426313

  • 21. Tungstate stimulates insulin release and inhibits somatostatin output in the perfused rat pancreas.
    Silvestre RA, Egido EM, Hernández R, Marco J.
    Eur J Pharmacol; 2005 Sep 05; 519(1-2):127-34. PubMed ID: 16126195
    [Abstract] [Full Text] [Related]

  • 22. In vitro insulinotropic action of a new non-sulfonylurea hypoglycemic agent, calcium (2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinyl-carbonyl) propionate dihydrate (KAD-1229), in rat pancreatic B-cells.
    Ohnota H, Kobayashi M, Koizumi T, Katsuno K, Sato F, Aizawa T.
    Biochem Pharmacol; 1995 Jan 18; 49(2):165-71. PubMed ID: 7840793
    [Abstract] [Full Text] [Related]

  • 23. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs.
    Beyer J, Haupt E, Cordes U, Kutschera J, Schöffling K.
    Horm Metab Res; 1973 Jan 18; 5(1):9-13. PubMed ID: 4196346
    [No Abstract] [Full Text] [Related]

  • 24. Effects of tolbutamide on insulin and glucagon secretion of the isolated perfused rat pancreas.
    Laube H, Fussgänger R, Goberna R, Schröder K, Straub K, Sussman K, Pfeiffer EF.
    Horm Metab Res; 1971 Jul 18; 3(4):238-42. PubMed ID: 4256979
    [No Abstract] [Full Text] [Related]

  • 25. [Insulin liberation from the pancreas by sulfonylurea].
    Pfaff W, Schöne HH.
    Arzneimittelforschung; 1969 Aug 18; 19(8):Suppl:1445-8. PubMed ID: 4899084
    [No Abstract] [Full Text] [Related]

  • 26. [Secretion of insulin under the influence of sulfonylurea derivates (SH)].
    Rothenbuchner G, Raptis S, Pfeiffer EF.
    Wien Z Inn Med; 1973 Aug 18; 54(2):69-77. PubMed ID: 4203274
    [No Abstract] [Full Text] [Related]

  • 27. Inhibition of transglutaminase by hypoglycaemic sulphonylureas in pancreatic islets and its possible relevance to insulin release.
    Gomis R, Mathias PC, Lebrun P, Malaisse-Lagae F, Sener A, Malaisse WJ.
    Res Commun Chem Pathol Pharmacol; 1984 Dec 18; 46(3):331-49. PubMed ID: 6151221
    [Abstract] [Full Text] [Related]

  • 28. Insulin release by tolbutamide and glibenclamide. A comparative study on the perfused rat pancreas.
    Joost HG, Hasselblatt A.
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Apr 18; 306(3):185-8. PubMed ID: 112482
    [Abstract] [Full Text] [Related]

  • 29. Pharmacodynamic aspects of two sulphonylurea derivatives glipizide and glibenclamide.
    Artini D, Abbiati R, Orsini G, Parenti MA, Bloch K, Daturi S, Mandelli V.
    Diabetologia; 1973 Sep 18; ():311-6. PubMed ID: 4204091
    [No Abstract] [Full Text] [Related]

  • 30. The effect of thyroxine treatment on the dynamics of insulin release from the isolated perfused rat pancreas.
    Lenzen S, Hasselblatt A.
    Naunyn Schmiedebergs Arch Pharmacol; 1974 Sep 18; 282(3):317-21. PubMed ID: 4277022
    [No Abstract] [Full Text] [Related]

  • 31. Effects of maltose on insulin secretion in perfused rat pancreas.
    Toyota T, Ando Y, Nishimura H, Hirata Y.
    Tohoku J Exp Med; 1971 Aug 18; 104(4):325-30. PubMed ID: 5124679
    [No Abstract] [Full Text] [Related]

  • 32. Enhancement by succinic acid dimethyl ester of insulin release evoked by D-glucose and glimepiride in the perfused pancreas of normoglycemic and hyperglycemic rats.
    Leclercq-Meyer V, Malaisse WJ.
    Biochem Pharmacol; 1994 Apr 29; 47(9):1519-24. PubMed ID: 8185662
    [Abstract] [Full Text] [Related]

  • 33. Pharmacological study of a new hypoglycaemic sulphonamide: glisoxepid (RP 22410).
    Loubatières A, Mariani MM, Ribes G, Alric R, Agot H.
    Diabetologia; 1972 Feb 29; 8(1):29-36. PubMed ID: 4554823
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Sulfonylureas stimulate renin secretion from the perfused kidney of the rat.
    Ochi H, Ikeda T.
    Nephron; 1999 Jan 29; 81(1):67-71. PubMed ID: 9884422
    [Abstract] [Full Text] [Related]

  • 36. [Synergetic action between glucose and hypotlycemic sulfamides on insulin secretion].
    Loubatières A, Mariani MM, Chapal J.
    C R Acad Hebd Seances Acad Sci D; 1968 Jul 01; 267(1):123-6. PubMed ID: 4971521
    [No Abstract] [Full Text] [Related]

  • 37. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets.
    Panten U, Burgfeld J, Goerke F, Rennicke M, Schwanstecher M, Wallasch A, Zünkler BJ, Lenzen S.
    Biochem Pharmacol; 1989 Apr 15; 38(8):1217-29. PubMed ID: 2650685
    [Abstract] [Full Text] [Related]

  • 38. Suppression of pancreatic glucagon release by the hypoglycaemic sulphonylureas.
    Samols E, Tyler JM, Mialhe P.
    Lancet; 1969 Jan 25; 1(7587):174-6. PubMed ID: 4178416
    [No Abstract] [Full Text] [Related]

  • 39. Metabolic, cationic and secretory effects of hypoglycemic sulfonylureas in pancreatic islets.
    Kawazu S, Sener A, Couturier E, Malaisse WJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jul 25; 312(3):277-83. PubMed ID: 6995864
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.